Arkolith/Insider Trading/KRTX/Form 4

Paul Steven M

DirectorKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
18
7 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)2K$330.00$675K9K
Mar 18, 2024Disposed to issuer(D)36K$330.00$11.8M0
Mar 18, 2024Disposed to issuer(D)30K$330.00$10.0M0
Mar 18, 2024Disposed to issuer(D)34K$330.00$11.2M0
Mar 18, 2024Disposed to issuer(D)10K$330.00$3.3M0
Mar 18, 2024Disposed to issuer(D)30K$330.00$10.0M0
Mar 18, 2024Disposed to issuer(D)9K$330.00$2.8M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)23K$142.74$3.3M0
Mar 18, 2024Disposed to issuer(D)147K$218.03$32.0M0
Mar 18, 2024Disposed to issuer(D)162K$198.36$32.1M0
Mar 18, 2024Disposed to issuer(D)136K$230.28$31.3M0
Mar 18, 2024Disposed to issuer(D)71K$309.98$22.0M0
Mar 18, 2024Disposed to issuer(D)15K$320.80$4.9M0
Mar 18, 2024Disposed to issuer(D)87K$320.80$28.1M0
Mar 18, 2024Disposed to issuer(D)449K$320.80$144.2M0
Mar 18, 2024Disposed to issuer(D)757K$322.73$244.3M0
Mar 18, 2024Disposed to issuer(D)136K$322.96$44.0M0
Mar 18, 2024Disposed to issuer(D)617K$314.00$193.6M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-013933) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML